Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.

Monti, Sara; Montecucco, Carlomaurizio

Monti, Sara; Montecucco, Carlomaurizio.

Monti S; Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy sara.saramonti@gmail.com.
Montecucco C; Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.

Ann Rheum Dis ; 80(3): e40, 2021 03.

Article in English | MEDLINE | ID: covidwho-1909647

Subject(s)

Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Familial Mediterranean Fever; Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Colchicine/therapeutic use; Familial Mediterranean Fever/drug therapy; Humans

Keywords

antirheumatic agents; cytokines; familial Mediterranean fever

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Familial Mediterranean Fever / Arthritis, Rheumatoid / Antirheumatic Agents / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-217957

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google